Implantable Defibrillators Market Overview:
Implantable Defibrillators Market was valued at $6,006 million in 2015 and is expected to garner $8,449 million by 2022, registering a CAGR of 4.9% during the forecast period 2016 - 2022. The demand for implantable defibrillators is expected to increase globally during the forecast period due to rapid increase in geriatric population and rise in incidence of sudden cardiac arrest (SCA). However, factors such as lack of awareness towards the advantage of using implantable defibrillators, high cost of implantable defibrillators, and unfavorable reimbursement policies are anticipated to hamper the market growth. Rise in demand for ICDs for patients with nonischemic cardiomyopathy reduces the risk of mortality to about 23%, which is expected to offer new opportunities for the market players.
The implantable defibrillators market is segmented based on product type and geography. On the basis of product type, the market is categorized into transvenous implantable cardioverter-defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillators (S-ICDS), and cardiac resynchronization therapy defibrillator (CRT-D). Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Argentina, Egypt, Israel, South Africa, and rest of LAMEA).
Implantable Defibrillators Market Segmentation
Drivers, restraints, and opportunities
The impact of the driving factors is expected to surpass that of the restraints. Moreover, emergence of new technologies and increase in adoption of S-ICDs are anticipated to provide new growth opportunities in the near future.
Drivers, Restraints And Opportunities Implantable Defibrillators
Global Implantable Defibrillators Market, By Geography, 2014-2022, ($Million)
North America held the largest market share in 2015, followed by Europe. However, Asia-Pacific is anticipated to register the highest CAGR owing to the large pool of patient population; increase in prevalence of cardiac disorders, arrhythmias, and sudden cardiac arrest; rise in demand for long-lasting battery life for ICD devices; improvement in healthcare infrastructure; and growth in geriatric population.
The key players operating in the global implantable defibrillators market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.
This report provides an extensive analysis of the current & emerging market trends and dynamics in the global implantable defibrillators market.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise market conditions are analyzed in the report.
Implantable Defibrillators Market Key Segments:
By Product Type
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA